Your browser doesn't support javascript.
loading
Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: a pilot study.
Alunno, A; Carubbi, F; Bistoni, O; Caterbi, S; Bartoloni, E; Di Benedetto, P; Cipriani, P; Giacomelli, R; Gerli, R.
Afiliación
  • Alunno A; Rheumatology Section, Department of Medicine, University of Perugia, Perugia, Italy.
  • Carubbi F; Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Bistoni O; Rheumatology Section, Department of Medicine, University of Perugia, Perugia, Italy.
  • Caterbi S; Rheumatology Section, Department of Medicine, University of Perugia, Perugia, Italy.
  • Bartoloni E; Rheumatology Section, Department of Medicine, University of Perugia, Perugia, Italy.
  • Di Benedetto P; Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Cipriani P; Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Giacomelli R; Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Gerli R; Rheumatology Section, Department of Medicine, University of Perugia, Perugia, Italy.
Clin Exp Immunol ; 184(3): 284-92, 2016 Jun.
Article en En | MEDLINE | ID: mdl-26814615
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome de Sjögren / Antígenos CD20 / Interleucina-17 / Células Th17 / Rituximab / Factores Inmunológicos Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: Clin Exp Immunol Año: 2016 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome de Sjögren / Antígenos CD20 / Interleucina-17 / Células Th17 / Rituximab / Factores Inmunológicos Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: Clin Exp Immunol Año: 2016 Tipo del documento: Article País de afiliación: Italia